Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces the appointment of Wade Rosen to the Company's Board as a Non-Executive Director with immediate effect.
Mr Rosen joins the board following the completion of the strategic investment in the Company by Rosen's Diversified, Inc. (RDI) pursuant to which it was agreed that RDI would be entitled to nominate a non-executive director. Mr Rosen is a successful business leader, entrepreneur, and co-founder of two business-to-business technology companies, ThrivePass Inc. ("ThrivePass") and Wishlist Rewards LLC ("Wishlist"). Mr Rosen currently serves as a Director of RDI, and as Executive Vice President at Scientific Life Solutions, a subsidiary of RDI. He also serves as a Director for Wishlist and Flagship Biosciences, Inc. and as Chairman of the Board at ThrivePass. Mr. Rosen holds a Bachelor of Business Administration (BBA) in Information Technology & E-Commerce from The University of Denver, and a Masters of Business Administration (MBA) from the Instituto de Empresa in Spain.
David Evans, Chairman of Collagen Solutions, said:"We are delighted to welcome Wade to the Board. Wade arrives at a pivotal time for the Company and we are confident that his appointment will bring immediate value to the Board."
Pursuant to Schedule 2 (g) of the AIM Rules for Companies, Wade John Rosen (aged 34) has held the following directorships or partnerships in the past five years:
Wellness by Wishlist Inc (doing business as ThrivePass Inc.)
Wishlist Rewards LLC
Flagship Biosciences Inc.
Rosen's Diversified Inc.
Connect First Inc.
Mr Rosen does not currently directly hold any shares in the Company but is a director and shareholder of RDI, which holds 83,600,000 Ordinary Shares.
There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.
Collagen Solutions Plc
Jamal Rushdy, CEO
Hilary Spence, CFO
Cenkos Securities Plc (Nominated Adviser and Broker)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Collagen Solutions (LON: COS) CEO Jamal Rushdy joined Steve Darling from Proactive to discuss the company releasing their financial numbers that show impressive double-digit sales growth.
Rushdy talks about the numbers and also their tissue division that continues to be a revenue driver.